216 related articles for article (PubMed ID: 2901953)
1. The structure of the human CD2 gene and its expression in transgenic mice.
Lang G; Wotton D; Owen MJ; Sewell WA; Brown MH; Mason DY; Crumpton MJ; Kioussis D
EMBO J; 1988 Jun; 7(6):1675-82. PubMed ID: 2901953
[TBL] [Abstract][Full Text] [Related]
2. Deletion analysis of the human CD2 gene locus control region in transgenic mice.
Lang G; Mamalaki C; Greenberg D; Yannoutsos N; Kioussis D
Nucleic Acids Res; 1991 Nov; 19(21):5851-6. PubMed ID: 1682894
[TBL] [Abstract][Full Text] [Related]
3. Human CD2 3'-flanking sequences confer high-level, T cell-specific, position-independent gene expression in transgenic mice.
Greaves DR; Wilson FD; Lang G; Kioussis D
Cell; 1989 Mar; 56(6):979-86. PubMed ID: 2564317
[TBL] [Abstract][Full Text] [Related]
4. Expression cloning of an equine T-lymphocyte glycoprotein CD2 cDNA. Structure-based analysis of conserved sequence elements.
Tavernor AS; Kydd JH; Bodian DL; Jones EY; Stuart DI; Davis SJ; Butcher GW
Eur J Biochem; 1994 Feb; 219(3):969-76. PubMed ID: 7906650
[TBL] [Abstract][Full Text] [Related]
5. Exon-intron organization and sequence comparison of human and murine T11 (CD2) genes.
Diamond DJ; Clayton LK; Sayre PH; Reinherz EL
Proc Natl Acad Sci U S A; 1988 Mar; 85(5):1615-9. PubMed ID: 2894031
[TBL] [Abstract][Full Text] [Related]
6. The structural biology of CD2.
Moingeon P; Chang HC; Sayre PH; Clayton LK; Alcover A; Gardner P; Reinherz EL
Immunol Rev; 1989 Oct; 111():111-44. PubMed ID: 2576417
[TBL] [Abstract][Full Text] [Related]
7. Structure, expression, and genetic linkage of the mouse BCM1 (OX45 or Blast-1) antigen. Evidence for genetic duplication giving rise to the BCM1 region on mouse chromosome 1 and the CD2/LFA3 region on mouse chromosome 3.
Wong YW; Williams AF; Kingsmore SF; Seldin MF
J Exp Med; 1990 Jun; 171(6):2115-30. PubMed ID: 1693656
[TBL] [Abstract][Full Text] [Related]
8. Fc gamma RII/III and CD2 expression mark distinct subpopulations of immature CD4-CD8- murine thymocytes: in vivo developmental kinetics and T cell receptor beta chain rearrangement status.
Rodewald HR; Awad K; Moingeon P; D'Adamio L; Rabinowitz D; Shinkai Y; Alt FW; Reinherz EL
J Exp Med; 1993 Apr; 177(4):1079-92. PubMed ID: 8096236
[TBL] [Abstract][Full Text] [Related]
9. Expression of soluble recombinant glycoproteins with predefined glycosylation: application to the crystallization of the T-cell glycoprotein CD2.
Davis SJ; Puklavec MJ; Ashford DA; Harlos K; Jones EY; Stuart DI; Williams AF
Protein Eng; 1993 Feb; 6(2):229-32. PubMed ID: 8097313
[No Abstract] [Full Text] [Related]
10. The biology of human CD2.
Reinherz EL; Chang HC; Clayton LK; Gardner P; Howard FD; Koyasu S; Jin YJ; Moingeon P; Sayre PH
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():611-25. PubMed ID: 2577023
[No Abstract] [Full Text] [Related]
11. Towards a molecular understanding of T-cell differentiation.
Clevers HC; Owen MJ
Immunol Today; 1991 Feb; 12(2):86-92. PubMed ID: 1676267
[TBL] [Abstract][Full Text] [Related]
12. Mechanism of lymphocyte function-associated molecule 3-Ig fusion proteins inhibition of T cell responses. Structure/function analysis in vitro and in human CD2 transgenic mice.
Majeau GR; Meier W; Jimmo B; Kioussis D; Hochman PS
J Immunol; 1994 Mar; 152(6):2753-67. PubMed ID: 7511625
[TBL] [Abstract][Full Text] [Related]
13. Separable portions of the CD2 cytoplasmic domain involved in signaling and ligand avidity regulation.
Hahn WC; Bierer BE
J Exp Med; 1993 Nov; 178(5):1831-6. PubMed ID: 7901319
[TBL] [Abstract][Full Text] [Related]
14. Immunological consequences of T cell-specific expression of H-2Kb molecules in transgenic mice.
Simpson SJ; Tomlinson P; Mellor AL
Int Immunol; 1993 Feb; 5(2):189-98. PubMed ID: 8095799
[TBL] [Abstract][Full Text] [Related]
15. Involvement of the PPPGHR motif in T cell activation via CD2.
Chang HC; Moingeon P; Pedersen R; Lucich J; Stebbins C; Reinherz EL
J Exp Med; 1990 Jul; 172(1):351-5. PubMed ID: 1972730
[TBL] [Abstract][Full Text] [Related]
16. A soluble multimeric recombinant CD2 protein identifies CD48 as a low affinity ligand for human CD2: divergence of CD2 ligands during the evolution of humans and mice.
Arulanandam AR; Moingeon P; Concino MF; Recny MA; Kato K; Yagita H; Koyasu S; Reinherz EL
J Exp Med; 1993 May; 177(5):1439-50. PubMed ID: 7683037
[TBL] [Abstract][Full Text] [Related]
17. Activators of protein kinase C up-regulate the cell surface expression of CD2 and CD5 T cell glycoproteins.
Carrera AC; Cárdenas L; Tugores A; Alonso M; Sánchez-Madrid F; de Landázuri MO
J Biol Chem; 1989 Sep; 264(26):15650-5. PubMed ID: 2475505
[TBL] [Abstract][Full Text] [Related]
18. Mouse LFA-3 studied with chimeric soluble CD2 shows preferential expression on lymphoid cells.
Rutschmann R; Karjalainen K
Eur J Immunol; 1991 Jun; 21(6):1379-84. PubMed ID: 1710564
[TBL] [Abstract][Full Text] [Related]
19. Dissection of the human CD2 intracellular domain. Identification of a segment required for signal transduction and interleukin 2 production.
Chang HC; Moingeon P; Lopez P; Krasnow H; Stebbins C; Reinherz EL
J Exp Med; 1989 Jun; 169(6):2073-83. PubMed ID: 2567337
[TBL] [Abstract][Full Text] [Related]
20. Structure-function relationships of the human T lymphocyte CD2 antigen.
Brown MH; Monostori E; Gullberg M; Zamoyska R; Lang G; Kioussis D; Crumpton MJ
Cold Spring Harb Symp Quant Biol; 1989; 54 Pt 2():627-36. PubMed ID: 2577024
[No Abstract] [Full Text] [Related]
[Next] [New Search]
